| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/21/1999 | WO1999002659A2 Method of altering the domains of cyclosporin synthetase to give a modified cyclosporin synthetase |
| 01/21/1999 | WO1999002654A1 Isolation of bone and cartilage precursor cells |
| 01/21/1999 | WO1999002564A2 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 01/21/1999 | WO1999002562A1 Isolated dendritic cell membrane protein genes |
| 01/21/1999 | WO1999002561A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation |
| 01/21/1999 | WO1999002556A1 Semaphorin receptors |
| 01/21/1999 | WO1999002552A2 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 01/21/1999 | WO1999002187A2 Decreased fat absorption with an anti-lipase antibody |
| 01/21/1999 | WO1999002185A1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/21/1999 | WO1998048025A3 Regulatory system for inducible expression of genes with lambdoid promoters |
| 01/21/1999 | WO1998047922A3 Determination of recombinant glycosylated proteins and peptides in biological fluids |
| 01/21/1999 | WO1998046273A3 Delivery system for gene therapy to the brain |
| 01/21/1999 | WO1998024810A3 Vertebrate homologues of unc-53 protein of c. elegans |
| 01/21/1999 | CA2659180A1 Trichoderma reesei swollenin protein and encoding dna sequences |
| 01/21/1999 | CA2295914A1 Antibodies and scfv immunotoxins specific to imported fire ants, and their application |
| 01/21/1999 | CA2295908A1 New human growth regulator protein |
| 01/21/1999 | CA2295735A1 Decreased fat absorption with an anti-lipase antibody |
| 01/21/1999 | CA2295539A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 01/21/1999 | CA2295218A1 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 01/21/1999 | CA2295202A1 Method of increasing the iron content of plant cells |
| 01/21/1999 | CA2295149A1 Fusion proteins with an immunoglobulin hinge region linker |
| 01/21/1999 | CA2295136A1 Cloning of the prolyl-dipeptidyl-peptidase from aspergillus oryzae |
| 01/21/1999 | CA2295086A1 Wa545 compositions |
| 01/21/1999 | CA2292791A1 Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein |
| 01/21/1999 | CA2263947A1 Enhanced expression of proteolytic enzymes in koji mold |
| 01/20/1999 | EP0892061A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratB |
| 01/20/1999 | EP0892060A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA |
| 01/20/1999 | EP0892057A2 Response regulator |
| 01/20/1999 | EP0892052A1 Sodium-bicarbonate transporter polypeptides |
| 01/20/1999 | EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor |
| 01/20/1999 | EP0892050A2 Human HFIZG53 |
| 01/20/1999 | EP0892049A2 A human pelota homolog |
| 01/20/1999 | EP0892048A2 XAF genes and polypeptides and their use for modulating apoptosis |
| 01/20/1999 | EP0892047A2 Human and murine semaphorin L |
| 01/20/1999 | EP0892046A2 Melatonin-receptor expression cells and their uses |
| 01/20/1999 | EP0891985A1 Process for the production of biologically active protein (e.g. TGF) |
| 01/20/1999 | EP0891984A2 Nucleic acid encoding streptococcus pneumoniae response regulator |
| 01/20/1999 | EP0891983A1 Novel tarF |
| 01/20/1999 | EP0891549A2 Foetal cell analysis |
| 01/20/1999 | EP0891428A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 01/20/1999 | EP0891427A1 Expression of hgv antigens and their use |
| 01/20/1999 | EP0891426A2 Human bikunin |
| 01/20/1999 | EP0891425A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 01/20/1999 | EP0891424A1 Human cachexia associated protein |
| 01/20/1999 | EP0891374A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 01/20/1999 | EP0891372A1 Growth factor htter36 |
| 01/20/1999 | EP0792288B1 Conjugates of bdnf and nt-3 with a water-soluble polymer |
| 01/20/1999 | EP0759986B1 Diagnostics for cancers expressing tyrosine phosphorylated crkl protein |
| 01/20/1999 | EP0734450B1 Methods for controlling sialic acid derivatives in recombinant glycoproteins |
| 01/20/1999 | EP0656908B1 Use of specific binding molecules in potentiating igf-i activity |
| 01/20/1999 | EP0613496B1 Collagen-like polypeptides |
| 01/20/1999 | EP0597960B1 Treatment of cell populations |
| 01/20/1999 | CN1205742A Movel process for preparing N-acetyl(L)-4-cyanophenylalanine Ac-(L)-phe(4-CN)-OH and N-acetyl-(L)-p-amidinophenylalantne-cyclohexylglycine-'beta'-(3-N-methylpyridinium)-alanine Ac-(L)-pAph-Chg-PalMe(3 |
| 01/20/1999 | CN1205738A OB protein derivatives having prolonged half-life |
| 01/20/1999 | CN1205613A Hybrid matrix implants and explants |
| 01/20/1999 | CN1205361A Disinfect peptide-X gene structure, prodn. tech. and use |
| 01/19/1999 | US5861543 Dna and amino acid sequences encoding a protein; plant cells such as corn transformed by the dna to be resistant to lepidopteran insects |
| 01/19/1999 | US5861499 Nucleic acid molecules encoding the variable or hypervariable region of a monoclonal antibody that binds to an extracellular domain |
| 01/19/1999 | US5861497 Trabecular meshwork induced glucocorticoid response (TIGR) nucleic acid molecules |
| 01/19/1999 | US5861490 Cd8 suppressor molecule, fractionation of media and identification of fractions |
| 01/19/1999 | US5861488 Gene therapy and gene expression of antisickling globulin proteins |
| 01/19/1999 | US5861484 Treatment of psoriasis, rheumatoid arthritis, hemangiomas, angiofibromas, diabetic retinopathy, neovascular glaucoma,and other vegf-induced pathological angiogenesis and vascular permeability conditions, such as tumor vascularization |
| 01/19/1999 | US5861480 Capable of isolation from seeds of aralia or impatiens exhibit antifungal and antibacterial activity |
| 01/19/1999 | US5861378 Polypeptides having specified amino acid sequences; antiseptics, effective against grampositive and gramnegative bacteria |
| 01/19/1999 | US5861377 Antistasin type serine protease inhibitors |
| 01/19/1999 | US5861375 Compounds for treatment of malaria, toxoplasmosis and coccidiosis |
| 01/19/1999 | US5861309 Amino acid sequences encoding it, vectors for its expression in yeast, bacterial, and mammalian cells; research into the characterization of the pharmacology of individual human alpha 1 receptor subtypes |
| 01/19/1999 | US5861308 Isolated nucleic acids associated with T cell activation and uses thereof |
| 01/19/1999 | US5861307 Liposomes embedded with dna; antitumor agents; apotosis |
| 01/19/1999 | US5861299 Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals |
| 01/19/1999 | US5861284 Method for producing a biologically active recombinant cysteine-free parathyroid hormone (1-34) |
| 01/19/1999 | US5861280 Host cell expressing reduced levels of a metalloprotease and methods using the host cell in protein production |
| 01/19/1999 | US5861276 CDNAS encoding murine antibody against human plasma apolipoprotein B-100 |
| 01/19/1999 | US5861275 Lantibiotic mutants and chimeras of enhanced stability and activity, leader sequences therefor, genes encoding the same, and methods of producing and using the same |
| 01/19/1999 | US5861273 Inserting a copy of a gene encoding the heterologous protein of interest into the chromosome of a host cell |
| 01/19/1999 | US5861259 Immunoassays for human cyclin E |
| 01/19/1999 | US5861157 An immunogenic fragment obtained from a bacterial protein capable of eliciting antibody response |
| 01/19/1999 | US5861155 Humanized antibodies and uses thereof |
| 01/19/1999 | US5861151 Soluble fusion molecules with binding specificity for cell adhesion molecules |
| 01/19/1999 | US5861150 Recombinant human CSF-1 dimer and compositions thereof |
| 01/19/1999 | CA2105382C Recombinant hybrid porin epitopes |
| 01/19/1999 | CA1340327C Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 01/19/1999 | CA1340322C Human papillomavirus type 41, its dna and the proteins encoded therefrom |
| 01/18/1999 | CA2237147A1 Novel ratb |
| 01/18/1999 | CA2237143A1 Novel rata |
| 01/18/1999 | CA2237140A1 Novel tarf |
| 01/18/1999 | CA2237043A1 Response regulator |
| 01/16/1999 | CA2237784A1 Novel compounds |
| 01/15/1999 | CA2220849A1 A human pelota homolog |
| 01/14/1999 | WO1999001565A1 Method for increasing secretion of proteins in eukaryotic host cells |
| 01/14/1999 | WO1999001556A2 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES |
| 01/14/1999 | WO1999001554A1 Mammalian secretory peptide-9 |
| 01/14/1999 | WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them |
| 01/14/1999 | WO1999001548A2 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
| 01/14/1999 | WO1999001471A1 Nik proteins, nucleic acids and methods |
| 01/14/1999 | WO1999001466A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | WO1999001020A2 19 human secreted proteins |
| 01/14/1999 | WO1998050555A3 Enterococcus faecalis polynucleotides and polypeptides |
| 01/14/1999 | WO1998050431A3 A method for making multispecific antibodies having heteromultimeric and common components |
| 01/14/1999 | WO1998037179A3 Fermentative production of valuable compounds on an industrial scale using chemically defined media |